Home/Companies/MedTech/MedLumics

MedLumics

MedTech·

France·Active·9yr hold

Entry

2017

Hold

9yr

Status

Active

Who owns MedLumics?

MedLumics is a French MedTech company, currently owned by Origine SGR since 2017 and 2 other investors.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY

Most recent investor

Andera Partners

BioDiscovery 5 · 2017 · VC

3 ownership periods · full history below

Key facts

HQFrance

SectorMedTech

Ownership history

3 ownership periods · co-invest detected

Active

Co-held by Ysios Capital Partners, Origine SGR and Andera Partners since 2011.

Co-invest · 3 holders · 2011 · present

Ysios Capital PartnersActive

2011 · present(15yr) · Ysios BioFund I · 2008 · Life Sciences VC

Andera PartnersActive

2017 · present(9yr) · BioDiscovery 5 · 2017 · VC

Origine SGRActive

2017 · present(9yr) · Innogest Capital II · 2015 · VC

More from BioDiscovery 5

Other portfolio companies in the same fund.

to Public market (NYSE IPO ticker EVMN)

to Public market (Nasdaq IPO ticker AGMB)

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Adicon Holdings Limited

Questions

Who owns MedLumics?

MedLumics is currently owned by Origine SGR, Andera Partners and 1 other, through BioDiscovery 5, since 2017.

When did Origine SGR and 2 others acquire MedLumics?

Origine SGR and 2 others acquired MedLumics in 2017.

Who has owned MedLumics over time?

MedLumics has been through 3 private-equity ownership periods: Ysios Capital Partners · via Ysios BioFund I · since 2011; Origine SGR · via Innogest Capital II · since 2017; Andera Partners · via BioDiscovery 5 · since 2017.

Look up another firm or company

Data refreshed weekly · Sourced from public filings · Report an issue